Kurozumi, Sasagu http://orcid.org/0000-0002-9971-2918
Alsaeed, Sami
Orah, Nnamdi
Miligy, Islam M.
Joseph, Chitra
Aljohani, Abrar
Toss, Michael S.
Fujii, Takaaki
Shirabe, Ken
Green, Andrew R.
Aleskandarany, Mohammed A.
Rakha, Emad A.
Funding for this research was provided by:
Pathological Society of Great Britain and Ireland (2201)
Article History
Received: 2 July 2019
Accepted: 29 October 2019
First Online: 9 November 2019
Compliance with ethical standards
:
: KS has received research grants from CHUGAI Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. The remaining authors declare that they have no conflicts of interest.
: This study was approved by the Nottingham Research Ethics Committee 2 (Reference title: Development of a molecular genetic classification of breast cancer). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all participants in the study.